| Term 
 
        | indications for TElavancin: |  | Definition 
 
        | 1. MRSA 2. VISA
 3. daptomycin/linezolid (R) S. aureus
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | dose adjustment required for telavancin in: |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | indications for aminoglycosides: |  | Definition 
 
        | EFFECTIVELY Tx G- INFECTIONS |  | 
        |  | 
        
        | Term 
 
        | explain the combo therapy of aminoglycosides: |  | Definition 
 
        | with serious infections (ex. endocarditis) B-lactams are given with aminoglycosides; the BL help the aminoglycosides to enter the cell |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. Gentamycin 2. Tobramycin
 |  | 
        |  | 
        
        | Term 
 
        | aminoglycosides spectrum of activity: |  | Definition 
 
        | 1. G+ (w BL combo) 2. G-
 3.
 |  | 
        |  | 
        
        | Term 
 
        | Therapeutic Drug levels of aminoglycosides and ADRs: |  | Definition 
 
        | Peak: MDD 4-10, ODD 16-24 Trough: <1mg/L
 can lead to ototoxicity/renal toxicity
 |  | 
        |  | 
        
        | Term 
 
        | when should aminoglycoside peaks be drawn? |  | Definition 
 
        | 30-60min after injection/infusion |  | 
        |  |